CEO: | Jeremy Skillington |
CFO: | Ian O’Connel |
Executive Chairman: | Cathal Friel |
Independent Non-Executive Director: | Edward Gibson |
Independent Non-Executive Director: | Luke O’Neill |
Independent Non-Executive Director: | Brendan Buckley |
Non-Executive Dir: |
Address: | 40 Bank Street, Floor 24, London, United Kingdom, E14 5NR |
Phone: | +44 (0)20 7183 1499 |
Website: | http://www.poolbegpharma.com/ |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BKPG7Z60 |
Currency | UK Pounds |
Share Price | 3.57p |
Change Today | -0.28p |
% Change | -7.36 % |
52 Week High | 14.25 |
52 Week Low | 2.40 |
Volume | 13,322,774 |
Shares Issued | 500.00m |
Market Cap | £17.83m |
Beta | 0.04 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:18 | 1 @ 3.58p |
16:14 | 1 @ 3.58p |
16:13 | 50,000 @ 3.58p |
16:07 | 19,945 @ 3.59p |
16:07 | 1 @ 3.58p |
CEO | Jeremy Skillington |
CFO | Ian O’Connel |
You are here: research